Skip to main content
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
editorial
. 1991 Apr;67(786):327–329. doi: 10.1136/pgmj.67.786.327

Inhaled corticosteroids in pulmonary sarcoidosis.

M A Spiteri
PMCID: PMC2398817  PMID: 2068023

Full text

PDF
327

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ainslie G. M., Poulter L. W., du Bois R. M. Relation between immunocytological features of bronchoalveolar lavage fluid and clinical indices in sarcoidosis. Thorax. 1989 Jun;44(6):501–509. doi: 10.1136/thx.44.6.501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Campbell D. A., Poulter L. W., du Bois R. M. Immunocompetent cells in bronchoalveolar lavage reflect the cell populations in transbronchial biopsies in pulmonary sarcoidosis. Am Rev Respir Dis. 1985 Dec;132(6):1300–1306. doi: 10.1164/arrd.1985.132.6.1300. [DOI] [PubMed] [Google Scholar]
  3. Ceuppens J. L., Lacquet L. M., Mariën G., Demedts M., van den Eeckhout A., Stevens E. Alveolar T-cell subsets in pulmonary sarcoidosis. Correlation with disease activity and effect of steroid treatment. Am Rev Respir Dis. 1984 Apr;129(4):563–568. [PubMed] [Google Scholar]
  4. Hunninghake G. W., Garrett K. C., Richerson H. B., Fantone J. C., Ward P. A., Rennard S. I., Bitterman P. B., Crystal R. G. Pathogenesis of the granulomatous lung diseases. Am Rev Respir Dis. 1984 Sep;130(3):476–496. doi: 10.1164/arrd.1984.130.3.476. [DOI] [PubMed] [Google Scholar]
  5. Lacronique J. G., Rennard S. I., Bitterman P. B., Ozaki T., Crystal R. G. Alveolar macrophages in idiopathic pulmonary fibrosis have glucocorticoid receptors, but glucocorticoid therapy does not suppress alveolar macrophage release of fibronectin and alveolar macrophage derived growth factor. Am Rev Respir Dis. 1984 Sep;130(3):450–456. doi: 10.1164/arrd.1984.130.3.450. [DOI] [PubMed] [Google Scholar]
  6. Pinkston P., Saltini C., Müller-Quernheim J., Crystal R. G. Corticosteroid therapy suppresses spontaneous interleukin 2 release and spontaneous proliferation of lung T lymphocytes of patients with active pulmonary sarcoidosis. J Immunol. 1987 Aug 1;139(3):755–760. [PubMed] [Google Scholar]
  7. Selroos O. B. Use of budesonide in the treatment of pulmonary sarcoidosis. Ann N Y Acad Sci. 1986;465:713–721. doi: 10.1111/j.1749-6632.1986.tb18550.x. [DOI] [PubMed] [Google Scholar]
  8. Spiteri M. A., Clarke S. W., Poulter L. W. Phenotypic and functional changes in alveolar macrophages contribute to the pathogenesis of pulmonary sarcoidosis. Clin Exp Immunol. 1988 Dec;74(3):359–364. [PMC free article] [PubMed] [Google Scholar]
  9. Spiteri M. A., Newman S. P., Clarke S. W., Poulter L. W. Inhaled corticosteroids can modulate the immunopathogenesis of pulmonary sarcoidosis. Eur Respir J. 1989 Mar;2(3):218–224. [PubMed] [Google Scholar]
  10. Spiteri M. A., Poulter L. W., Geraint-James D. The macrophage in sarcoid granuloma formation. Sarcoidosis. 1989 Oct;6 (Suppl 1):12–14. [PubMed] [Google Scholar]
  11. Williams M. H., Jr Beclomethasone dipropionate. Ann Intern Med. 1981 Oct;95(4):464–467. doi: 10.7326/0003-4819-95-4-464. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES